July 9, 2020 / 1:35 PM / a month ago

BRIEF-Pulmatrix - In Discussions With Cipla On Termination Of Pulmazole Phase 2 Clinical Study & Initiation Of New Phase 2B/ 3 Clinical Study During In Mid-2021

July 9 (Reuters) - Pulmatrix Inc:

* PULMATRIX - IN DISCUSSIONS WITH CIPLA ON TERMINATION OF PULMAZOLE PHASE 2 CLINICAL STUDY & INITIATION OF NEW PHASE 2B/ 3 CLINICAL STUDY DURING IN MID-2021 Source text for Eikon: [ID: bit.ly/3205FxJ] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below